COMMUNIQUÉS West-GlobeNewswire
-
Oculis to Participate in Upcoming Investor Conferences
05/03/2026 -
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
05/03/2026 -
Oculis to Participate in Upcoming Investor Conferences
05/03/2026 -
Swarm Oncology appoints Bernhard Ehmer as Chairman
05/03/2026 -
Oculis Publishes 2025 Consolidated Financial Statements
05/03/2026 -
BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call
05/03/2026 -
Phonak Infinio Ultra Sphere and Virto R Infinio win 2026 iF DESIGN AWARD
05/03/2026 -
NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
05/03/2026 -
SugarHarmony Consumer Concerns Under Investigation: Critiquing The Sugar Harmony Claims
05/03/2026 -
Purisaki Berberine Patches Claims Evaluated: 2026 Consumer Report on Transdermal Berberine Delivery, Patch Absorption Science, and What Buyers Should Verify
05/03/2026 -
Medline Inc. announces pricing of secondary offering of class A common stock
05/03/2026 -
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
04/03/2026 -
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance
04/03/2026 -
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
04/03/2026 -
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/03/2026 -
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
04/03/2026 -
LB Pharmaceuticals to Participate in Upcoming March Investor Events
04/03/2026 -
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
04/03/2026 -
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/03/2026
Pages